These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

363 related articles for article (PubMed ID: 27760429)

  • 1. Cerebrospinal Fluid Progranulin, but Not Serum Progranulin, Is Reduced in GRN-Negative Frontotemporal Dementia.
    Wilke C; Gillardon F; Deuschle C; Hobert MA; Jansen IE; Metzger FG; Heutink P; Gasser T; Maetzler W; Blauwendraat C; Synofzik M
    Neurodegener Dis; 2017; 17(2-3):83-88. PubMed ID: 27760429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Novel Splice-Acceptor Site Mutation in GRN (c.709-2 A>T) Causes Frontotemporal Dementia Spectrum in a Large Family from Southern Italy.
    Sassi C; Capozzo R; Gibbs R; Crews C; Zecca C; Arcuti S; Copetti M; Barulli MR; Brescia V; Singleton AB; Logroscino G
    J Alzheimers Dis; 2016 May; 53(2):475-85. PubMed ID: 27258413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cerebrospinal fluid soluble TREM2 levels in frontotemporal dementia differ by genetic and pathological subgroup.
    Woollacott IOC; Nicholas JM; Heslegrave A; Heller C; Foiani MS; Dick KM; Russell LL; Paterson RW; Keshavan A; Fox NC; Warren JD; Schott JM; Zetterberg H; Rohrer JD
    Alzheimers Res Ther; 2018 Aug; 10(1):79. PubMed ID: 30111356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inflammatory molecules in Frontotemporal Dementia: cerebrospinal fluid signature of progranulin mutation carriers.
    Galimberti D; Bonsi R; Fenoglio C; Serpente M; Cioffi SM; Fumagalli G; Arighi A; Ghezzi L; Arcaro M; Mercurio M; Rotondo E; Scarpini E
    Brain Behav Immun; 2015 Oct; 49():182-7. PubMed ID: 26021560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum Levels of Progranulin Do Not Reflect Cerebrospinal Fluid Levels in Neurodegenerative Disease.
    Wilke C; Gillardon F; Deuschle C; Dubois E; Hobert MA; Müller vom Hagen J; Krüger S; Biskup S; Blauwendraat C; Hruscha M; Kaeser SA; Heutink P; Maetzler W; Synofzik M
    Curr Alzheimer Res; 2016; 13(6):654-62. PubMed ID: 26971930
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cerebrospinal Fluid YKL-40 and Chitotriosidase Levels in Frontotemporal Dementia Vary by Clinical, Genetic and Pathological Subtype.
    Woollacott IOC; Nicholas JM; Heller C; Foiani MS; Moore KM; Russell LL; Paterson RW; Keshavan A; Schott JM; Warren JD; Heslegrave A; Zetterberg H; Rohrer JD
    Dement Geriatr Cogn Disord; 2020; 49(1):56-76. PubMed ID: 32344399
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Partial Tmem106b reduction does not correct abnormalities due to progranulin haploinsufficiency.
    Arrant AE; Nicholson AM; Zhou X; Rademakers R; Roberson ED
    Mol Neurodegener; 2018 Jun; 13(1):32. PubMed ID: 29929528
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progranulin Protein Levels in Cerebrospinal Fluid in Primary Neurodegenerative Dementias.
    Morenas-Rodríguez E; Cervera-Carles L; Vilaplana E; Alcolea D; Carmona-Iragui M; Dols-Icardo O; Ribosa-Nogué R; Muñoz-Llahuna L; Sala I; Belén Sánchez-Saudinós M; Blesa R; Clarimón J; Fortea J; Lleó A
    J Alzheimers Dis; 2016; 50(2):539-46. PubMed ID: 26682689
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma phosphorylated TDP-43 levels are elevated in patients with frontotemporal dementia carrying a C9orf72 repeat expansion or a GRN mutation.
    Suárez-Calvet M; Dols-Icardo O; Lladó A; Sánchez-Valle R; Hernández I; Amer G; Antón-Aguirre S; Alcolea D; Fortea J; Ferrer I; van der Zee J; Dillen L; Van Broeckhoven C; Molinuevo JL; Blesa R; Clarimón J; Lleó A
    J Neurol Neurosurg Psychiatry; 2014 Jun; 85(6):684-91. PubMed ID: 24309270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progranulin AAV gene therapy for frontotemporal dementia: translational studies and phase 1/2 trial interim results.
    Sevigny J; Uspenskaya O; Heckman LD; Wong LC; Hatch DA; Tewari A; Vandenberghe R; Irwin DJ; Saracino D; Le Ber I; Ahmed R; Rohrer JD; Boxer AL; Boland S; Sheehan P; Brandes A; Burstein SR; Shykind BM; Kamalakaran S; Daniels CW; David Litwack E; Mahoney E; Velaga J; McNamara I; Sondergaard P; Sajjad SA; Kobayashi YM; Abeliovich A; Hefti F
    Nat Med; 2024 May; 30(5):1406-1415. PubMed ID: 38745011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cerebrospinal fluid biomarkers in Progranulin mutations carriers.
    Carecchio M; Fenoglio C; Cortini F; Comi C; Benussi L; Ghidoni R; Borroni B; De Riz M; Serpente M; Cantoni C; Franceschi M; Albertini V; Monaco F; Rainero I; Binetti G; Padovani A; Bresolin N; Scarpini E; Galimberti D
    J Alzheimers Dis; 2011; 27(4):781-90. PubMed ID: 21891865
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GRN and MAPT Mutations in 2 Frontotemporal Dementia Research Centers in Brazil.
    Takada LT; Bahia VS; Guimarães HC; Costa TV; Vale TC; Rodriguez RD; Porto FH; Machado JC; Beato RG; Cesar KG; Smid J; Nascimento CF; Grinberg LT; Brucki SM; Maximino JR; Camargos ST; Chadi G; Caramelli P; Nitrini R
    Alzheimer Dis Assoc Disord; 2016; 30(4):310-317. PubMed ID: 27082848
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inflammatory plasma profile in genetic symptomatic and presymptomatic Frontotemporal Dementia - A GENFI study.
    Fenoglio C; Serpente M; Arcaro M; Carandini T; Sacchi L; Pintus M; Rotondo E; Borracci V; Ghezzi L; Bouzigues A; Russell LL; Foster PH; Ferry-Bolder E; van Swieten JC; Jiskoot LC; Seelaar H; Sánchez Valle R; Laforce R; Graff C; Vandenberghe R; de Mendonça A; Tiraboschi P; Santana I; Gerhard A; Levin J; Sorbi S; Otto M; Pasquier F; Ducharme S; Butler CR; Ber IL; Finger E; Carmela Tartaglia M; Masellis M; Rowe JB; Synofzik M; Moreno F; Borroni B; Rohrer JD; Arighi A; Galimberti D;
    Brain Behav Immun; 2024 Nov; 122():231-240. PubMed ID: 39153518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel frameshift GRN mutation results in frontotemporal lobar degeneration with a distinct clinical phenotype in two siblings: case report and literature review.
    Hosaka T; Ishii K; Miura T; Mezaki N; Kasuga K; Ikeuchi T; Tamaoka A
    BMC Neurol; 2017 Sep; 17(1):182. PubMed ID: 28915852
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frontotemporal Dementia due to the Novel GRN Arg161GlyfsX36 Mutation.
    Gazzina S; Archetti S; Alberici A; Bonomi E; Cosseddu M; Di Lorenzo D; Padovani A; Borroni B
    J Alzheimers Dis; 2017; 57(4):1185-1189. PubMed ID: 28304311
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular characterization of novel progranulin (GRN) mutations in frontotemporal dementia.
    Mukherjee O; Wang J; Gitcho M; Chakraverty S; Taylor-Reinwald L; Shears S; Kauwe JS; Norton J; Levitch D; Bigio EH; Hatanpaa KJ; White CL; Morris JC; Cairns NJ; Goate A
    Hum Mutat; 2008 Apr; 29(4):512-21. PubMed ID: 18183624
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cerebral blood flow in presymptomatic MAPT and GRN mutation carriers: A longitudinal arterial spin labeling study.
    Dopper EG; Chalos V; Ghariq E; den Heijer T; Hafkemeijer A; Jiskoot LC; de Koning I; Seelaar H; van Minkelen R; van Osch MJ; Rombouts SA; van Swieten JC
    Neuroimage Clin; 2016; 12():460-5. PubMed ID: 27625986
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impaired β-glucocerebrosidase activity and processing in frontotemporal dementia due to progranulin mutations.
    Arrant AE; Roth JR; Boyle NR; Kashyap SN; Hoffmann MQ; Murchison CF; Ramos EM; Nana AL; Spina S; Grinberg LT; Miller BL; Seeley WW; Roberson ED
    Acta Neuropathol Commun; 2019 Dec; 7(1):218. PubMed ID: 31870439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigating the role of filamin C in Belgian patients with frontotemporal dementia linked to GRN deficiency in FTLD-TDP brains.
    Janssens J; Philtjens S; Kleinberger G; Van Mossevelde S; van der Zee J; Cacace R; Engelborghs S; Sieben A; Banzhaf-Strathmann J; Dillen L; Merlin C; Cuijt I; Robberecht C; Schmid B; Santens P; Ivanoiu A; Vandenbulcke M; Vandenberghe R; Cras P; De Deyn PP; Martin JJ; Maudsley S; Haass C; Cruts M; Van Broeckhoven C;
    Acta Neuropathol Commun; 2015 Nov; 3():68. PubMed ID: 26555887
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutations in progranulin (GRN) within the spectrum of clinical and pathological phenotypes of frontotemporal dementia.
    van Swieten JC; Heutink P
    Lancet Neurol; 2008 Oct; 7(10):965-74. PubMed ID: 18771956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.